AstraZeneca Archives - Page 3 of 27 - Express Pharma

Targeted therapies and improved diagnostics remain needs unmet in T2-low asthma

Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030

AstraZeneca invests $3.5 bn in R&D and manufacturing in the US

AstraZeneca India, Indian Academy of Paediatrics unite to raise awareness on respiratory syncytial virus in India

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

AstraZeneca to launch Palivizumab (Synagis) in India

Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030

AstraZeneca says lung cancer drug trial shows no significant improvement in overall survival

Top 20 global biopharma companies report 4.3% growth in market capitalisation in Q2 2024, reveals GlobalData

US FDA approves AstraZeneca’s non-small cell lung cancer treatment